Search

Your search keyword '"Storm, A."' showing total 139 results
Start Over Author "Storm, A." Journal european journal of cancer
139 results on '"Storm, A."'

2. Geographical variability in survival of European children with central nervous system tumours

Author

Hackl, M., Zielonke, N., Oberaigner, W., Van Eycken, E., Henau, K., Valerianova, Z., Dimitrova, N., Sekerija, M., Storm, H., Engholm, G., Mägi, M., Aareleid, T., Malila, N., Seppä, K., Faivre, J., Bossard, N., Uhry, Z., Colonna, M., Clavel, J., Lacour, B., Desandes, E., Brenner, H., Kaatsch, P., Katalinic, A., Garami, M., Jakab, Z., Comber, H., Mazzoleni, G., Bulatko, A., Buzzoni, C., Giacomin, A., Sutera Sardo, A., Mancuso, P., Ferretti, S., Barchielli, A., Caldarella, A., Gatta, G., Sant, M., Amash, H., Amati, C., Baili, P., Berrino, F., Bonfarnuzzo, S., Botta, L., Capocaccia, R., Di Salvo, F., Foschi, R., Margutti, C., Meneghini, E., Minicozzi, P., Trama, A., Serraino, D., Zucchetto, A., De Angelis, R., Caldora, M., Carrani, E., Francisci, S., Mallone, S., Pierannunzio, D., Roazzi, P., Rossi, S., Santaquilani, M., Tavilla, A., Pannozzo, F., Busco, S., Filiberti, R.A., Marani, E., Ricci, P., Pascucci, C., Autelitano, M., Spagnoli, G., Cirilli, C., Fusco, M., Vitale, M.F., Usala, M., Vitale, F., Ravazzolo, B., Michiara, M., Merletti, F., Maule, M., Tumino, R., Mangone, L., Di Felice, E., Falcini, F., Iannelli, A., Sechi, O., Cesaraccio, R., Piffer, S., Madeddu, A., Tisano, F., Maspero, S., Fanetti, A.C., Candela, P., Scuderi, T., Stracci, F., Bianconi, F., Tagliabue, G., Contiero, P., Rugge, M., Guzzinati, S., Pildava, S., Smailyte, G., Calleja, N., Agius, D., Johannesen, T.B., Rachtan, J., Góźdź, S., Mężyk, R., Błaszczyk, J., Bębenek, M., Bielska-Lasota, M., Forjaz de Lacerda, G., Bento, M.J., Castro, C., Miranda, A., Mayer-da-Silva, A., Safaei Diba, C., Primic-Zakelj, M., Errezola, M., Bidaurrazaga, J., Vicente Raneda, M., Díaz García, J.M., Marcos-Navarro, A.I., Marcos-Gragera, R., Izquierdo Font, A., Sanchez, M.J., Chang, D.Y.L., Navarro, C., Chirlaque, M.D., Moreno-Iribas, C., Ardanaz, E., Peris-Bonet, R., Pardo Romaguera, E., Galceran, J., Carulla, M., Lambe, M., Mousavi, M., Bouchardy, C., Usel, M., Ess, S.M., Frick, H., Lorez, M., Herrmann, C., Bordoni, A., Spitale, A., Konzelmann, I., Visser, O., Aarts, M., Otter, R., Coleman, M., Allemani, C., Rachet, B., Verne, J., Stiller, C., Gavin, A., Donnelly, C., Brewster, D.H., Sánchez, M.-J., and Rutkowski, S.

Published
2017
Full Text
View/download PDF

4. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

Author

Hackl, M., Zielonke, N., Van Eycken, E., Henau, K., Valerianova, Z., Dimitrova, N., Sekerija, M., Dušek, L., Zvolský, M., Storm, H., Engholm, G., Mägi, M., Aareleid, T., Malila, N., Seppä, K., Velten, M., Guizard, A.V., Faivre, J., Woronoff, A.S., Tretarre, B., Bossard, N., Uhry, Z., Colonna, M., Molinié, F., Bara, S., Schvartz, C., Lapôtre-Ledoux, B., Grosclaude, P., Stabenow, R., Luttmann, S., Eberle, A., Brenner, H., Nennecke, A., Engel, J., Schubert-Fritschle, G., Heidrich, J., Holleczek, B., Katalinic, A., Jónasson, J.G., Tryggvadóttir, L., Comber, H., Mazzoleni, G., Bulatko, A., Buzzoni, C., Giacomin, A., Sutera Sardo, A., Mazzei, A., Ferretti, S., Barchielli, A., Caldarella, A., Gatta, G., Sant, M., Amash, H., Amati, C., Baili, P., Berrino, F., Bonfarnuzzo, S., Botta, L., Capocaccia, R., Di Salvo, F., Foschi, R., Margutti, C., Meneghini, E., Minicozzi, P., Trama, A., Serraino, D., Zucchetto, A., De Angelis, R., Caldora, M., Carrani, E., Francisci, S., Mallone, S., Pierannunzio, D., Roazzi, P., Rossi, S., Santaquilani, M., Tavilla, A., Pannozzo, F., Busco, S., Filiberti, R.A., Vercelli, M., Ricci, P., Autelitano, M., Spagnoli, G., Cirilli, C., Fusco, M., Vitale, M.F., Usala, M., Vitale, F., Ravazzolo, B., Michiara, M., Tumino, R., Mangone, L., Vicentini, M., Falcini, F., Iannelli, A., Sechi, O., Cesaraccio, R., Piffer, S., Madeddu, A., Tisano, F., Maspero, S., Fanetti, A.C., Zanetti, R., Rosso, S., Candela, P., Scuderi, T., Stracci, F., Rocca, A., Tagliabue, G., Contiero, P., Rugge, M., Tognazzo, S., Pildava, S., Smailyte, G., Calleja, N., Agius, D., Johannesen, T.B., Rachtan, J., Góźdź, S., Mężyk, R., Błaszczyk, J., Bębenek, M., Bielska-Lasota, M., Forjaz de Lacerda, G., Bento, M.J., Castro, C., Miranda, A., Mayer-da-Silva, A., Safaei Diba, C., Primic-Zakelj, M., Errezola, M., Bidaurrazaga, J., Díaz García, J.M., Marcos-Navarro, A.I., Marcos-Gragera, R., Izquierdo Font, A., Sanchez, M.J., Molina, E., Navarro, C., Chirlaque, M.D., Moreno-Iribas, C., Ardanaz, E., Galceran, J., Carulla, M., Lambe, M., Khan, S., Mousavi, M., Bouchardy, C., Usel, M., Ess, S.M., Frick, H., Lorez, M., Herrmann, C., Bordoni, A., Spitale, A., Konzelmann, I., Visser, O., Ho, V., Otter, R., Coleman, M., Allemani, C., Rachet, B., Rashbass, J., Broggio, J., Verne, J., Gavin, A., Donnelly, C., Brewster, D.H., Huws, D.W., White, C., Dal Maso, L., Pacini, F., van Dijk, B.A.C., Larrañaga, N., Rubió-Casadevall, J., Kowalska, A., and Virdone, S.

Published
2017
Full Text
View/download PDF

7. Tobacco-related cancers in Europe: The scale of the epidemic in 2018

Author

Ivana Kulhánová, Hermann Brenner, Isabelle Soerjomataram, Linda Bauld, David Forman, Carolina Espina, Jérôme Vignat, and Hans H. Storm

Subjects
Male, 0301 basic medicine, Cancer Research, Laryngeal Cancers, Population, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Tobacco, Prevalence, Humans, Medicine, Epidemics, education, Lung cancer, education.field_of_study, business.industry, Incidence, Smoking, Tobacco control, Pharynx, Cancer, medicine.disease, Europe, 030104 developmental biology, medicine.anatomical_structure, Oncology, Cancer incidence, 030220 oncology & carcinogenesis, Attributable risk, Female, business, Demography
Abstract

Background Tobacco smoking is the major preventable cause of cancer. Despite the longstanding decline in smoking prevalence, lung cancer remains one of the most frequently diagnosed cancers in both sexes. We aimed to estimate the current cancer burden attributable to smoking in Europe. Methods Smoking-related cancer incidence by country, cancer type, sex and age in Europe was estimated from GLOBOCAN 2018. We applied a modified version of the indirect method to estimate the population attributable fraction (PAF) for lung cancer and applied Levin's formula to estimate the PAF for other smoking-related cancer sites. Results In Europe in 2018, 572,000 and 186,000 cancer cases were attributable to tobacco smoking in males and females respectively, accounting for 28% (males) and 10% (females) of all cancer cases. By region, the largest and the lowest PAF due to smoking in males occurred in Eastern Europe (35% of all cancer cases) and Northern Europe (21%), respectively. Among women, this pattern was reversed (16% in Northern Europe and 6% in Eastern Europe). Lung cancer accounted for more than half of the total cancer burden attributable to smoking (382,000). Other major contributors to the total PAF were lip, oral cavity and pharynx, bladder and laryngeal cancers in men (27% out of total PAF) and colorectal, pancreatic, oral cavity and pharyngeal cancers (21%) in women. Conclusions Tobacco smoking was responsible for one in five cancer cases in Europe in 2018. The introduction and robust implementation of tobacco control programmes are critical to reduce this cancer burden in the future.

Published
2020

8. Avoidable cancers in the Nordic countries—The impact of alcohol consumption

Author

Hans H. Storm, Therese M.-L. Andersson, Gerda Engholm, Magnus Stenbeck, Eero Pukkala, Laufey Tryggvadottir, and Elisabete Weiderpass

Subjects
Male, Cancer Research, Alcohol Drinking, Colorectal cancer, Alcohol, Scandinavian and Nordic Countries, Oral cavity, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Neoplasms, Environmental health, Cancer burden, medicine, Humans, 030212 general & internal medicine, Potential impact, Cancer prevention, business.industry, Cancer, medicine.disease, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, business, Alcohol consumption
Abstract

Background Alcohol consumption is an important and preventable cause of cancer. The aim of this study was to quantify the proportion of the cancer burden in the Nordic countries linked to alcohol and estimate the potential for cancer prevention by changes in alcohol consumption. Methods Using the Prevent macro-simulation model, the number of cancer cases in the Nordic countries over a 30-year period (2016–2045) was modelled for six sites, under different scenarios of changing alcohol consumption, and compared to the projected number of cases if constant alcohol consumption prevailed. The studied sites were colorectal, post-menopausal breast, oral cavity and pharynx, liver, larynx as well as oesophageal squamous cell carcinoma. The alcohol consumption was based on the categories of non-drinkers/occasional drinkers, light drinkers ( 12.5 and ≤ 50 g/day) and heavy drinkers (>50 g/day). Results About 83,000 cancer cases could be avoided in the Nordic countries in a 30-year period if alcohol consumption was entirely eliminated, which is 5.5% of the expected number of cases for the six alcohol-related cancer types. With a 50% reduction in the proportion with moderate alcohol consumption by year 2025, 21,500 cancer cases could be avoided. The number of avoidable cases was highest for post-menopausal breast and colorectal cancer, but the percentage was highest for oesophageal squamous cell carcinoma. Conclusion The results from this study can be used to understand the potential impact and significance of primary prevention programmes targeted towards reducing the alcohol consumption in the Nordic countries.

Published
2018

10. Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology

Author

Berdien Oortgiesen, A.M. Van Der Wal-Oost, Huib Storm, E.N. Van Roon, Nic J. G. M. Veeger, Robby E. Kibbelaar, Karin Boslooper, Mels Hoogendoorn, J.W.W. Coebergh, Peter Joosten, and Public Health

Subjects
INFERENTIAL GAP, Cancer Research, medicine.medical_specialty, Pediatrics, EUROPE, Best practice, Electronic health record, Population, Alternative medicine, HEMATOLOGICAL MALIGNANCIES, Medical Oncology, Randomised clinical trial, DISEASE, law.invention, Population-based registry, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Medicine, Data Mining, Electronic Health Records, Humans, Medical physics, 030212 general & internal medicine, Registries, education, Randomized Controlled Trials as Topic, education.field_of_study, MULTIPLE-MYELOMA PATIENTS, Evidence-Based Medicine, business.industry, Public health, Data Collection, B-CELL LYMPHOMA, Evidence-based medicine, Hematology, PHAROS-REGISTRY, Clinical trial, Oncology, 030220 oncology & carcinogenesis, PUBLIC-HEALTH, SURVIVAL, Observational study, Medical Record Linkage, NETHERLANDS CANCER REGISTRY, business, Haematology
Abstract

Randomised clinical trials (RCTs) are considered the basis of evidence-based medicine. It is recognised more and more that application of RCT results in daily practice of clinical decision-making is limited because the RCT world does not correspond with the clinical real world. Recent strategies aiming at substitution of RCT databases by improved population-based registries (PBRs) or by improved electronic health record (EHR) systems to provide significant data for clinical science are discussed. A novel approach exemplified by the HemoBase haemato-oncology project is presented. In this approach, a PBR is combined with an advanced EHR, providing high-quality data for observational studies and support of best practice development. This PBR + EHR approach opens a perspective on randomised registry trials.

Published
2017

13. Avoidable cancers in the Nordic countries—the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer

Author

Andersson, Therese M-L., primary, Engholm, Gerda, additional, Lund, Anne-Sofie Q., additional, Lourenço, Sofia, additional, Matthiessen, Jeppe, additional, Pukkala, Eero, additional, Stenbeck, Magnus, additional, Tryggvadottir, Laufey, additional, Weiderpass, Elisabete, additional, and Storm, Hans, additional

Published
2019
Full Text
View/download PDF

16. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

Author

Roberta De Angelis, Pamela Minicozzi, Milena Sant, Luigino Dal Maso, David H. Brewster, Gemma Osca-Gelis, Otto Visser, Marc Maynadié, Rafael Marcos-Gragera, Xavier Troussard, Dominic Agius, Paolo Roazzi, Elisabetta Meneghini, Alain Monnereau, M. Hackl, N. Zielonke, W. Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, N. Dimitrova, M. Sekerija, M. Zvolský, L. Dušek, H. Storm, G. Engholm, M. Mägi, T. Aareleid, N. Malila, K. Seppä, M. Velten, X. Troussard, V. Bouvier, G. Launoy, A.V. Guizard, J. Faivre, A.M. Bouvier, P. Arveux, M. Maynadié, A.S. Woronoff, M. Robaszkiewicz, I. Baldi, A. Monnereau, B. Tretarre, N. Bossard, A. Belot, M. Colonna, F. Molinié, S. Bara, C. Schvartz, B. Lapôtre-Ledoux, P. Grosclaude, M. Meyer, R. Stabenow, S. Luttmann, A. Eberle, H. Brenner, A. Nennecke, J. Engel, G. Schubert-Fritschle, J. Kieschke, J. Heidrich, B. Holleczek, A. Katalinic, J.G. Jónasson, L. Tryggvadóttir, H. Comber, G. Mazzoleni, A. Bulatko, C. Buzzoni, A. Giacomin, A. Sutera Sardo, P. Mancuso, S. Ferretti, E. Crocetti, A. Caldarella, G. Gatta, M. Sant, H. Amash, C. Amati, P. Baili, F. Berrino, S. Bonfarnuzzo, L. Botta, F. Di Salvo, R. Foschi, C. Margutti, E. Meneghini, P. Minicozzi, A. Trama, D. Serraino, L. Dal Maso, R. De Angelis, M. Caldora, R. Capocaccia, E. Carrani, S. Francisci, S. Mallone, D. Pierannunzio, P. Roazzi, S. Rossi, M. Santaquilani, A. Tavilla, F. Pannozzo, S. Busco, L. Bonelli, M. Vercelli, V. Gennaro, P. Ricci, M. Autelitano, G. Randi, M. Ponz De Leon, C. Marchesi, C. Cirilli, M. Fusco, M.F. Vitale, M. Usala, A. Traina, R. Staiti, F. Vitale, B. Ravazzolo, M. Michiara, R. Tumino, P. Giorgi Rossi, E. Di Felice, F. Falcini, A. Iannelli, O. Sechi, R. Cesaraccio, S. Piffer, A. Madeddu, F. Tisano, S. Maspero, A.C. Fanetti, R. Zanetti, S. Rosso, P. Candela, T. Scuderi, F. Stracci, F. Bianconi, G. Tagliabue, P. Contiero, A.P. Dei Tos, S. Guzzinati, S. Pildava, G. Smailyte, N. Calleja, D. Agius, T.B. Johannesen, J. Rachtan, S. Gózdz, R. Mezyk, J. Blaszczyk, M. Bebenek, M. Bielska-Lasota, G. Forjaz de Lacerda, M.J. Bento, C. Castro, A. Miranda, A. Mayer-da-Silva, F. Nicula, D. Coza, C. Safaei Diba, M. Primic-Zakelj, E. Almar, C. Ramírez, M. Errezola, J. Bidaurrazaga, A. Torrella-Ramos, J.M. Díaz García, R. Jimenez-Chillaron, R. Marcos-Gragera, A. Izquierdo Font, M.J. Sanchez, D.Y.L. Chang, C. Navarro, M.D. Chirlaque, C. Moreno-Iribas, E. Ardanaz, J. Galceran, M. Carulla, M. Lambe, S. Khan, M. Mousavi, C. Bouchardy, M. Usel, S.M. Ess, H. Frick, M. Lorez, C. Herrmann, A. Bordoni, A. Spitale, I. Konzelmann, O. Visser, V. Lemmens, M. Coleman, C. Allemani, B. Rachet, J. Verne, N. Easey, G. Lawrence, T. Moran, J. Rashbass, M. Roche, J. Wilkinson, A. Gavin, C. Donnelly, D.H. Brewster, D.W. Huws, C. White, and R. Otter

Subjects
Oncology, Cancer registry, Europe, Hodgkin lymphoma, Leukaemia, Lymphoma, Multiple myeloma, Non-Hodgkin lymphoma, Relative survival, Cancer Research, education.field_of_study, medicine.medical_specialty, Myeloid, business.industry, Population, Follicular lymphoma, Plasma cell neoplasm, medicine.disease, medicine.anatomical_structure, hemic and lymphatic diseases, Internal medicine, Immunology, Medicine, education, business, International Classification of Diseases for Oncology
Abstract

BACKGROUND: Significant advances in the management of patients with lymphoid and myeloid malignancies entered clinical practice in the early 2000's. The EUROCARE-5 study database provides an opportunity to assess the impact of these changes at the population level by country in Europe. We provide survival estimates for clinically relevant haematological malignancies (HM), using the International Classification of Diseases for Oncology 3, by country, gender and age in Europe. METHODS: We estimated age-standardised relative survival using the complete cohort approach for 625, 000 adult patients diagnosed in 2000-2007 and followed up to 2008. Survival information was provided by 89 participating cancer registries from 29 European countries. Mean survival in Europe was calculated as the population weighted average of country-specific estimates. RESULTS: On average in Europe, 5-year relative survival was highest for Hodgkin lymphoma (81% ; 40, 625 cases), poorest for acute myeloid leukaemia (17% ; 57, 026 cases), and intermediate for non- Hodgkin lymphoma (59% ; 329, 204 cases), chronic myeloid leukaemia (53% ; 17, 713 cases) and plasma cell neoplasms (39% ; 94, 024 cases). Survival was generally lower in Eastern Europe and highest in Central and Northern Europe. Wider between country differences (>10%) were observed for malignancies that benefited from therapeutic advances, such as chronic myeloid leukaemia, chronic lymphocytic leukaemia, follicular lymphoma, diffuse large B-cell lymphoma and multiple myeloma. Lower differences (

Published
2015

17. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

Author

Otto Visser, Eva Ardanaz, Laura Botta, Milena Sant, Andrea Tavilla, Pamela Minicozzi, M. Hackl, N. Zielonke, W. Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, N. Dimitrova, M. Sekerija, M. Zvolský, L. Dušek, H. Storm, G. Engholm, M. Mägi, T. Aareleid, N. Malila, K. Seppä, M. Velten, X. Troussard, V. Bouvier, G. Launoy, A.V. Guizard, J. Faivre, A.M. Bouvier, P. Arveux, M. Maynadié, A.S. Woronoff, M. Robaszkiewicz, I. Baldi, A. Monnereau, B. Tretarre, N. Bossard, A. Belot, M. Colonna, F. Molinié, S. Bara, C. Schvartz, B. Lapôtre-Ledoux, P. Grosclaude, M. Meyer, R. Stabenow, S. Luttmann, A. Eberle, H. Brenner, A. Nennecke, J. Engel, G. Schubert-Fritschle, J. Kieschke, J. Heidrich, B. Holleczek, A. Katalinic, J.G. Jónasson, L. Tryggvadóttir, H. Comber, G. Mazzoleni, A. Bulatko, C. Buzzoni, A. Giacomin, A. Sutera Sardo, P. Mancuso, S. Ferretti, E. Crocetti, A. Caldarella, G. Gatta, M. Sant, H. Amash, C. Amati, P. Baili, F. Berrino, S. Bonfarnuzzo, L. Botta, F. Di Salvo, R. Foschi, C. Margutti, E. Meneghini, P. Minicozzi, A. Trama, D. Serraino, L. Dal Maso, R. De Angelis, M. Caldora, R. Capocaccia, E. Carrani, S. Francisci, S. Mallone, D. Pierannunzio, P. Roazzi, S. Rossi, M. Santaquilani, A. Tavilla, F. Pannozzo, S. Busco, L. Bonelli, M. Vercelli, V. Gennaro, P. Ricci, M. Autelitano, G. Randi, M. Ponz De Leon, C. Marchesi, C. Cirilli, M. Fusco, M.F. Vitale, M. Usala, A. Traina, R. Staiti, F. Vitale, B. Ravazzolo, M. Michiara, R. Tumino, P. Giorgi Rossi, E. Di Felice, F. Falcini, A. Iannelli, O. Sechi, R. Cesaraccio, S. Piffer, A. Madeddu, F. Tisano, S. Maspero, A.C. Fanetti, R. Zanetti, S. Rosso, P. Candela, T. Scuderi, F. Stracci, F. Bianconi, G. Tagliabue, P. Contiero, A.P. Dei Tos, S. Guzzinati, S. Pildava, G. Smailyte, N. Calleja, D. Agius, T.B. Johannesen, J. Rachtan, S. Gózdz, R. Mezyk, J. Blaszczyk, M. Bebenek, M. Bielska-Lasota, G. Forjaz de Lacerda, M.J. Bento, C. Castro, A. Miranda, A. Mayer-da-Silva, F. Nicula, D. Coza, C. Safaei Diba, M. Primic-Zakelj, E. Almar, C. Ramírez, M. Errezola, J. Bidaurrazaga, A. Torrella-Ramos, J.M. Díaz García, R. Jimenez-Chillaron, R. Marcos-Gragera, A. Izquierdo Font, M.J. Sanchez, D.Y.L. Chang, C. Navarro, M.D. Chirlaque, C. Moreno-Iribas, E. Ardanaz, J. Galceran, M. Carulla, M. Lambe, S. Khan, M. Mousavi, C. Bouchardy, M. Usel, S.M. Ess, H. Frick, M. Lorez, C. Herrmann, A. Bordoni, A. Spitale, I. Konzelmann, O. Visser, R. Verhoeven, M. Coleman, C. Allemani, B. Rachet, J. Verne, N. Easey, G. Lawrence, T. Moran, J. Rashbass, M. Roche, J. Wilkinson, A. Gavin, C. Donnelly, D.H. Brewster, D.W. Huws, C. White, and R. Otter

Subjects
Oncology, Ependymoma, Cancer Research, medicine.medical_specialty, Pediatrics, Oligoastrocytoma, Relative survival, business.industry, Cancer, Astrocytoma, medicine.disease, Cancer registry, Internal medicine, medicine, Brain tumours, Survival, Oligodendroglioma, business, Pathological
Abstract

Background Primary malignant brain tumours are rare but represent a serious health burden due to their poor survival. This manuscript describes the survival of malignant brain tumours in adults diagnosed 2000–2007 in Europe. Methods For this study we analysed patients archived in 86 European population-based cancer registries, followed up to 31st December 2008. Only primary malignant neuroepithelial brain tumours (with pathological confirmation) and primary malignant unspecified brain tumours without pathological confirmation were included. We estimated 1-year and 5-year relative survival (RS) weighted by age group and country. We also estimated country-specific and age-specific survival, together with survival differences between time periods (for 1999–2001, 2002–2004 and 2005–2007). Results Glioblastoma represents 49% of all brain tumours, followed by other/unspecified astrocytoma (18%), oligodendroglioma/oligoastrocytoma (9%), ependymoma (1.5%) and embryonal tumours (1%). Five-year RS was 20% for all tumours combined, but ranged from 58% for ependymoma to only 6% for glioblastoma and sharply decreased with increasing age. Differences between countries were relatively small, but generally RS in Ireland/United Kingdom (UK) and Eastern Europe was below the average. An increase in 1-year RS (up to 10–12%) was noted over time, being largest in Central and Northern Europe in patients between 45 and 74 years of age. Conclusions Despite an increase in 1-year RS in most European regions, the survival of primary malignant brain tumours is still poor. Disparities between countries were evident, being even larger at the end of the study period than at the beginning, suggesting differences in availability of the latest treatment modalities.

Published
2015

18. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study

Author

Bernd Holleczek, Silvia Rossi, Agius Domenic, Kaire Innos, Pamela Minicozzi, Silvia Francisci, Monika Hackl, Nora Eisemann, Hermann Brenner, M. Hackl, N. Zielonke, W. Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, N. Dimitrova, M. Sekerija, M. Zvolský, L. Dušek, H. Storm, G. Engholm, M. Mägi, T. Aareleid, N. Malila, K. Seppä, M. Velten, X. Troussard, V. Bouvier, G. Launoy, A.V. Guizard, J. Faivre, A.M. Bouvier, P. Arveux, M. Maynadié, A.S. Woronoff, M. Robaszkiewicz, I. Baldi, A. Monnereau, B. Tretarre, N. Bossard, A. Belot, M. Colonna, F. Molinié, S. Bara, C. Schvartz, B. Lapôtre-Ledoux, P. Grosclaude, M. Meyer, R. Stabenow, S. Luttmann, A. Eberle, H. Brenner, A. Nennecke, J. Engel, G. Schubert-Fritschle, J. Kieschke, J. Heidrich, B. Holleczek, A. Katalinic, J.G. Jónasson, L. Tryggvadóttir, H. Comber, G. Mazzoleni, A. Bulatko, C. Buzzoni, A. Giacomin, A. Sutera Sardo, A. Mazzei, S. Ferretti, E. Crocetti, G. Manneschi, G. Gatta, M. Sant, H. Amash, C. Amati, P. Baili, F. Berrino, S. Bonfarnuzzo, L. Botta, F. Di Salvo, R. Foschi, C. Margutti, E. Meneghini, P. Minicozzi, A. Trama, D. Serraino, A. Zucchetto, R. De Angelis, M. Caldora, R. Capocaccia, E. Carrani, S. Francisci, S. Mallone, D. Pierannunzio, P. Roazzi, S. Rossi, M. Santaquilani, A. Tavilla, F. Pannozzo, M. Natali, L. Bonelli, M. Vercelli, V. Gennaro, P. Ricci, M. Autelitano, G. Randi, M. Ponz De Leon, C. Marchesi, C. Cirilli, M. Fusco, M.F. Vitale, M. Usala, A. Traina, M. Zarcone, F. Vitale, R. Cusimano, M. Michiara, R. Tumino, P. Giorgi Rossi, M. Vicentini, F. Falcini, A. Iannelli, O. Sechi, R. Cesaraccio, S. Piffer, A. Madeddu, F. Tisano, S. Maspero, A.C. Fanetti, R. Zanetti, S. Rosso, P. Candela, T. Scuderi, F. Stracci, A. Rocca, G. Tagliabue, P. Contiero, A.P. Dei Tos, S. Tognazzo, S. Pildava, G. Smailyte, N. Calleja, R. Micallef, T.B. Johannesen, J. Rachtan, S. Gózdz, R. Mezyk, J. Blaszczyk, K. Kepska, M. Bielska-Lasota, G. Forjaz de Lacerda, M.J. Bento, L. Antunes, A. Miranda, A. Mayer-da-Silva, F. Nicula, D. Coza, C. Safaei Diba, M. Primic-Zakelj, E. Almar, A. Mateos, M. Errezola, N. Larrañaga, A. Torrella-Ramos, J.M. Díaz García, A.I. Marcos-Navarro, R. Marcos-Gragera, L. Vilardell, M.J. Sanchez, E. Molina, C. Navarro, M.D. Chirlaque, C. Moreno-Iribas, E. Ardanaz, J. Galceran, M. Carulla, M. Lambe, S. Khan, M. Mousavi, C. Bouchardy, M. Usel, S.M. Ess, H. Frick, M. Lorez, C. Herrmann, A. Bordoni, A. Spitale, I. Konzelmann, O. Visser, V. Lemmens, M. Coleman, C. Allemani, B. Rachet, J. Verne, N. Easey, G. Lawrence, T. Moran, J. Rashbass, M. Roche, J. Wilkinson, A. Gavin, D. Fitzpatrick, D.H. Brewster, D.W. Huws, C. White, and R. Otter

Subjects
Cancer Research, medicine.medical_specialty, education.field_of_study, Relative survival, Colorectal cancer, business.industry, Cancer registries, EUROCARE-5 study, Population-based, Population, Age at diagnosis, Cancer, Rectum, Treatment options, medicine.disease, digestive system diseases, Surgery, medicine.anatomical_structure, Oncology, Internal medicine, Cohort, medicine, business, education
Abstract

Background Previous population-based studies revealed major variation in survival for patients with colorectal cancer (CRC) in Europe by age and between different countries and regions, but also a sustained improvement in survival for patients with CRC in recent years. This EUROCARE-5 paper aims to update available knowledge from previous studies and to provide the latest survival estimates for CRC patients from Europe. Methods The study analysed data of patients diagnosed with CRC from population-based cancer registries diagnosed in 29 European countries. Estimates of 1-year and 5-year relative survival (RS) were derived for patients diagnosed in 2000–2007 by European region, country and age at diagnosis. Additionally to these cohort estimates, time trends in 5-year RS were obtained for the calendar periods 1999–2001 and 2005–2007, using the period analysis methodology. Results European average 5-year RS for patients diagnosed with colon and rectum cancer was 57% and 56%, respectively. The analyses showed persistent differences in cancer survival across Europe with lowest survival for CRC patients observed in Eastern Europe. The analyses further showed a strong gradient in age-specific survival. Even though the study revealed sustained improvement in patient survival between 1999–2001 and 2005–2007 (absolute increase of 4 and 6 percentage points for colon and rectum, respectively), the differences in the survival for CRC patients observed at the beginning of the millennium persisted over time. Conclusion Although survival for CRC patients in Europe improved markedly in the study period, significant geographic variations and a strong age gradient still persisted. Enhanced access to effective diagnostic procedures and treatment options might be the keys to reducing the existing disparities in the survival of CRC patients across Europe.

Published
2015

19. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany – The Fehmarn Belt project

Author

Gerda Engholm, Niels Henrik Holländer, Anne Mette Tranberg Kejs, Alexander Katalinic, Jürgen Dunst, Ron Pritzkuleit, and Hans H. Storm

Subjects
Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, Colorectal cancer, Denmark, Young Adult, Germany, Health care, medicine, Humans, media_common.cataloged_instance, European Union, Registries, European union, Child, Survival analysis, Aged, media_common, Aged, 80 and over, Relative survival, business.industry, Incidence, Incidence (epidemiology), Infant, Newborn, Infant, Cancer, Middle Aged, medicine.disease, Survival Analysis, Surgery, Cancer registry, Oncology, Child, Preschool, Female, Colorectal Neoplasms, business, Demography
Abstract

International comparisons of cancer registry based survival are often used as a marker of the performance of health care services on cancer. These are debated for comparability, validity and lack of detail with respect to prognostic factors. With a view to cross border collaborative cancer research and care in the European Union (EU), we used the established routine registration systems for cancer in the neighbouring regions Zealand, Denmark, and Schleswig-Holstein, Germany, to study if available routine registration suffices for the study of diagnosis, treatment and follow-up for colorectal cancer patients. The aim was to assess to which extent differences in survival between the regions could be explained.Colorectal cancer patients recorded 2004-2010 in Schleswig-Holstein (colon: 10,631; rectum 5683) and region Zealand (colon: 3205; rectum 1747) were studied. Excluding cases aged 90+ or only known from death certificates, one- and four-year relative survival by stage for the periods 2004-2006 and 2007-2009 (one-year) were calculated.A high proportion of patients in Schleswig-Holstein were known only from death certificates (colon 11%; rectum 6.9%) compared to0.3% in region Zealand. Colon cancer incidence (asr-e) (men 36; women 28) and mortality (men 12; women 8.7) in Schleswig-Holstein were 10 per 100,000 lower than in Zealand; minor differences were seen for rectum cancer. One and four-year overall survival increased in both regions but was superior in Schleswig-Holstein. For patients with reported stage I-III, negligible differences in survival were seen; with further restriction to patients with treatment reported, even so in stage IV patients 2007-2009.Improved data quality and comparability than presently used in the large international survival studies is needed. If stage and treatment is taken into account, more valid international comparisons of cancer survival are possible. Reporting and follow-up must be improved and cases only known from death certificates (DCO) minimised. A high proportion DCO (excluded from analyses) may produce higher survival, whereas a low the opposite. Co-morbidity and socio-economic status should be included alongside other prognostic variables in survival studies. Barriers towards proper follow-up and monitoring of outcome e.g. privacy legislation must be considered with a view to future patient mobility.

Published
2015

20. Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?

Author

Hans H. Storm and Mette Rye Andersen

Subjects
Cancer Research, medicine.medical_specialty, Data Protection Directive, Neoplasms, medicine, Humans, media_common.cataloged_instance, Data Protection Act 1998, Confidentiality, Registries, European union, Computer Security, Health policy, media_common, Conflict of Interest, business.industry, Data Collection, Public health, Public relations, Quality Improvement, Cancer registry, Europe, Health Records, Personal, Oncology, Health Care Reform, General Data Protection Regulation, Health Services Research, Public Health, business
Abstract

The importance of cancer- and other disease registries for planning, management and evaluation of healthcare systems has been shown repeatedly during the last 50 years. Complete and unbiased population-level analyses on routinely collected, individual data concerning health and personal characteristics can address significant concerns about risk factors for cancer and provide sound evidence about public health and the effectiveness of healthcare systems. The existence of quality controlled and comprehensive data in registries, allowed to be used for quality control, research and public health purposes are taken as granted by most health professionals and researchers. However, the current revision of the European Union (EU) data protection framework suggests a harmonisation of requirements for confidentiality and individual consent to data processing, likely at the expense of proper use of registry data in the health sector. Consequences of excessive confidentiality rules that may lead to missed data linkages have been simulated. The simulations provide one possible explanation for observed heterogeneity among some cancer incidence data. Further, public health, quality control and epidemiological research on large populations can no longer provide evidence for health interventions, if requirements for consent renders research impossible or where attempts to obtain consent from each data subject generates biased results. Health professionals should engage in the on-going debate on the Commission's proposal for a General Data Protection Regulation. The nature and use of registry data in public health research must be explained and known to policy-makers and the public. Use of cancer registry data and other epidemiological activity will terminate abruptly if an unnecessarily strict EU data protection regulation is adopted. Research based interventions, as well as the international recognised standing of cancer registries and register-based research institutions in Europe are at stake.

Published
2015

21. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study

Author

Milena Sant, Maria Dolores Chirlaque Lopez, Roberto Agresti, Maria José Sánchez Pérez, Bernd Holleczek, Magdalena Bielska-Lasota, Nadya Dimitrova, Kaire Innos, Alexander Katalinic, Hilde Langseth, Nerea Larrañaga, Silvia Rossi, Sabine Siesling, Pamela Minicozzi, M. Hackl, N. Zielonke, W. Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, N. Dimitrova, M. Sekerija, M. Zvolský, L. Dušek, H. Storm, G. Engholm, M. Mägi, T. Aareleid, N. Malila, K. Seppä, M. Velten, X. Troussard, V. Bouvier, G. Launoy, A.V. Guizard, J. Faivre, A.M. Bouvier, P. Arveux, M. Maynadié, A.S. Woronoff, M. Robaszkiewicz, I. Baldi, A. Monnereau, B. Tretarre, N. Bossard, A. Belot, M. Colonna, F. Molinié, S. Bara, C. Schvartz, B. Lapôtre-Ledoux, P. Grosclaude, M. Meyer, R. Stabenow, S. Luttmann, A. Eberle, H. Brenner, A. Nennecke, J. Engel, G. Schubert-Fritschle, J. Kieschke, J. Heidrich, B. Holleczek, A. Katalinic, J.G. Jónasson, L. Tryggvadóttir, H. Comber, G. Mazzoleni, A. Bulatko, C. Buzzoni, A. Giacomin, A. Sutera Sardo, P. Mancuso, S. Ferretti, E. Crocetti, A. Caldarella, G. Gatta, M. Sant, H. Amash, C. Amati, P. Baili, F. Berrino, S. Bonfarnuzzo, L. Botta, F. Di Salvo, R. Foschi, C. Margutti, E. Meneghini, P. Minicozzi, A. Trama, D. Serraino, L. Dal Maso, R. De Angelis, M. Caldora, R. Capocaccia, E. Carrani, S. Francisci, S. Mallone, D. Pierannunzio, P. Roazzi, S. Rossi, M. Santaquilani, A. Tavilla, F. Pannozzo, S. Busco, L. Bonelli, M. Vercelli, V. Gennaro, P. Ricci, M. Autelitano, G. Randi, M. Ponz De Leon, C. Marchesi, C. Cirilli, M. Fusco, M.F. Vitale, M. Usala, A. Traina, R. Staiti, F. Vitale, B. Ravazzolo, M. Michiara, R. Tumino, P. Giorgi Rossi, E. Di Felice, F. Falcini, A. Iannelli, O. Sechi, R. Cesaraccio, S. Piffer, A. Madeddu, F. Tisano, S. Maspero, A.C. Fanetti, R. Zanetti, S. Rosso, P. Candela, T. Scuderi, F. Stracci, F. Bianconi, G. Tagliabue, P. Contiero, A.P. Dei Tos, S. Guzzinati, S. Pildava, G. Smailyte, N. Calleja, D. Agius, T.B. Johannesen, J. Rachtan, S. Gózdz, R. Mezyk, J. Blaszczyk, M. Bebenek, M. Bielska-Lasota, G. Forjaz de Lacerda, M.J. Bento, C. Castro, A. Miranda, A. Mayer-da-Silva, F. Nicula, D. Coza, C. Safaei Diba, M. Primic-Zakelj, E. Almar, C. Ramírez, M. Errezola, J. Bidaurrazaga, A. Torrella-Ramos, J.M. Díaz García, R. Jimenez-Chillaron, R. Marcos-Gragera, A. Izquierdo Font, M.J. Sanchez, D.Y.L. Chang, C. Navarro, M.D. Chirlaque, C. Moreno-Iribas, E. Ardanaz, J. Galceran, M. Carulla, M. Lambe, S. Khan, M. Mousavi, C. Bouchardy, M. Usel, S.M. Ess, H. Frick, M. Lorez, C. Herrmann, A. Bordoni, A. Spitale, I. Konzelmann, O. Visser, V. Lemmens, M. Coleman, C. Allemani, B. Rachet, J. Verne, N. Easey, G. Lawrence, T. Moran, J. Rashbass, M. Roche, J. Wilkinson, A. Gavin, C. Donnelly, D.H. Brewster, D.W. Huws, C. White, R. Otter, Health Technology & Services Research, and Faculty of Behavioural, Management and Social Sciences

Subjects
Gynecology, Cervical cancer, Cancer Research, medicine.medical_specialty, education.field_of_study, Vaginal cancer, Relative survival, business.industry, Obstetrics, Population, Cancer, Breast cancer, Corpus uteri cancer, Europe, Ovarian cancer, Population-based, Survival, Vulval cancer, Vulvar cancer, medicine.disease, medicine.anatomical_structure, Oncology, medicine, METIS-311843, IR-97294, business, education, Cervix
Abstract

BACKGROUND: Survival differences across Europe for patients with cancers of breast, uterus, cervix, ovary, vagina and vulva have been documented by previous EUROCARE studies. In the present EUROCARE-5 study we update survival estimates and investigate changes in country-specific and over time survival, discussing their relationship with incidence and mortality dynamics for cancers for which organised screening programs are ongoing. METHODS: We analysed cases archived in over 80 population-based cancer registries in 29 countries grouped into five European regions. We used the cohort approach to estimate 5-year relative survival (RS) for adult (⩾15years) women diagnosed 2000-2007, by age, country and region ; and the period approach to estimate time trends (1999-2007) in RS for breast and cervical cancers. RESULTS: In 2000-2007, 5-year RS was 57% overall, 82% for women diagnosed with breast, 76% with corpus uteri, 62% with cervical, 38% with ovarian, 40% with vaginal and 62% with vulvar cancer. Survival was low for patients resident in Eastern Europe (34% ovary-74% breast) and Ireland and the United Kingdom [Ireland/UK] (31-79%) and high for those resident in Northern Europe (41-85%) except Denmark. Survival decreased with advancing age: markedly for women with ovarian (71% 15-44years ; 20% ⩾75years) and breast (86% ; 72%) cancers. Survival for patients with breast and cervical cancers increased from 1999-2001 to 2005-2007, remarkably for those resident in countries with initially low survival. CONCLUSIONS: Despite increases over time, survival for women's cancers remained poor in Eastern Europe, likely due to advanced stage at diagnosis and/or suboptimum access to adequate care. Low survival for women living in Ireland/UK and Denmark could indicate late detection, possibly related also to referral delay. Poor survival for ovarian cancer across the continent and over time suggests the need for a major research effort to improve prognosis for this common cancer.

Published
2015

22. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees (R) in Europe: From roots to fruits

Author

Corina van den Hurk, Harry Comber, Stefano Rosso, Lidia Sacchetto, Hans H. Storm, Sabine Siesling, Roberto Zanetti, Evert Ben Van Veen, Janny Van Den Eijnden-Van Raaij, Marieke W. Louwman, Jan Willem Coebergh, Public Health, and Health Technology & Services Research

Subjects
Cancer Research, Pediatrics, medicine.medical_specialty, Population, Context (language use), Mass screening evaluation, Quality of life (healthcare), SDG 3 - Good Health and Well-being, Neoplasms, Humans, Medicine, media_common.cataloged_instance, European Union, Registries, European union, education, Mass screening, media_common, Biobank, Data protection, education.field_of_study, business.industry, Cancer in elderly, Data Collection, Public health, Clinical epidemiology, Ownership, Programme owner, Cancer, medicine.disease, Descriptive epidemiology, Europe, Oncology, Cancer registry ERA-net, Population Surveillance, Family medicine, Practice Guidelines as Topic, Patient Participation, business, Linking databases, Software, Quality of oncologic care
Abstract

Currently about 160 population-based cancer registries (CRs) in Europe have extensive experience in generating valid information on variation in cancer risk and survival with time and place. Most CRs cover all cancers, but some are confined to specific cancers or to children. They cover 15-55% of the populations in all of the larger member states of the European Union (EU), except the United Kingdom (UK), and 100% coverage in 80% of those with populations below 20 million. The EU FP 7 EUROCOURSE project, which operated in 20092013, explored the essential role of CRs in cancer research and public health, and also focused attention on their programme owners (POs) and stakeholders (e.g. cancer societies, oncological professionals, cancer patient groups, and planners, providers and evaluators of cancer care and mass screening). Generally, all CRs depended on their regional and/or national oncological context and were increasingly involved in population-based studies of quality of cancer care, long-term prognosis and quality of life, one third being very active. Within the public health domain, CRs, in addition to describing the variety of environmental and lifestyle-related cancer epidemics, have also contributed actively to aetiologic research by a European databases that showed wide discrepancies in cancer risk and survival across the EU, and in more depth by follow-up of cohorts and recruitment for case-control studies. CRs were also actively contributing to independent evaluation of mass screening as an intervention which affects quality of care and cancer mortality. The potential of CRs for clinical evaluation has grown substantially through interaction with clinical stakeholders and more incidentally biobanks, also with greater involvement of patient groups - with a special focus on elderly patients who generally do not take part in clinical trials. Whereas 25-35% of CRs are active in a range of cancer research areas, the rest have a low profile and usually provide only incidence and survival data. If they are unable to do so because POs and stakeholders do not demand it, they might also be inhibited by data protection restrictions, especially in German and French speaking countries. The value of population-based studies of quality of oncologic care and mass screening and the flawless reputation with regard to data protection of intensively used CRs in the northwest of Europe offered a sharp contrast, although they also follow the 1995 EU guideline on data protection. CRs thus offer a perfect example of what can be done with sensitive and minimal data, also when enriched by linkages to other databases. Intensive use of the data has allowed CR research departments to take on a visible expertise-based profile but a neutral in many public controversies in preventive oncology. Their management and fundability also appeared to benefit from externally classifying the wide array of tumour-or tract-specific intelligence and research activities for the various users in oncology and public health and also patients who are the source of the data - are better informed. Transparency on what CRs enable may also improve through programmes of research have been deemed essential to our funding POs (ministries, cancer charities, cancer centres or public health institutes) who might benefit from some guidance to - often suboptimal -governance. Therefore, a metaphoric RegisTree (R) has been developed for self-assessment and to clarify CR working methods and domain-specific performance to stakeholders and funding agencies, showing much room for development in many CRs. All in all, CRs are likely to remain unique sources of independent expert information on the burden of cancer, indispensable for cancer surveillance, with increased attention to cancer survivors, up to 4% of the population. Investments in the expanding CR network across Europe offer an excellent way forward for comparative future cancer surveillance with so many epidemiologic and clinical changes ahead. (C) 2015 Elsevier Ltd. All rights reserved.

Published
2015

25. Differences in survival from prostate cancer in Denmark, Iceland and Sweden

Author

Ea Rusch, Eirikur Jonsson, Klaus Brasso, Jan Adolfsson, Inga Jona Ingimarsdottir, Laufey Tryggvadottir, Hans H. Storm, Erik Holmberg, Anna Bill-Axelson, and Gerda Engholm

Subjects
Adult, Male, Gerontology, Cancer Research, Time Factors, Denmark, Population, Iceland, Disease, Cohort Studies, Prostate cancer, Humans, Medicine, Registries, Neoplasm Metastasis, education, Survival analysis, Aged, Neoplasm Staging, Aged, 80 and over, Sweden, education.field_of_study, Relative survival, business.industry, Incidence, Incidence (epidemiology), Prostatic Neoplasms, Cancer, Middle Aged, Prostate-Specific Antigen, Prognosis, medicine.disease, Survival Analysis, Survival Rate, Oncology, business, Cohort study, Demography
Abstract

Introduction Register-based studies have shown large survival differences among prostate cancer patients in the Nordic countries. The aim of this study was to determine the background of such differences in Denmark, Iceland and Sweden. Material and methods Patients with prostate cancer were identified through population-based cancer registers in the three countries. Clinical findings at diagnosis were retrieved from hospital records. In Sweden, clinical information was gathered from regional population-based prostate cancer registers. Country-specific incidence and excess mortality rates were compared, with adjustment for prognostic factors. Results The relative survival in the cohorts was comparable to that in previous population-based studies. Significant differences in excess mortality rates were found across countries, which diminished or disappeared after adjustment for patient characteristics, i.e. metastatic status, clinical T stage and prostate-specific antigen level. A difference in the proportion of patients with metastatic disease was the main explanation of the differences in survival among countries, while the incidence rates of metastatic cancer were similar. Discussion Register-based studies of the relative survival of prostate cancer patients are influenced by national differences in clinical presentation at diagnosis. Differences in the proportion of patients with metastatic spread explained most of the difference in relative survival among patients in Denmark, Iceland and Sweden. Future country comparisons of relative survival should include adjustment for differences in patient characteristics, such as stage, prostate-specific antigen level and screening intensity.

Published
2013

26. Impact of a smoking and alcohol intervention program on lung and breast cancer incidence in Denmark: An example of dynamic modeling with Prevent

Author

Henrik Brønnum-Hansen, Jan J. Barendregt, Gerda Engholm, Isabelle Soerjomataram, Hans H. Storm, Esther de Vries, Georg Paludan-Müller, and Public Health

Subjects
Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Adolescent, Alcohol Drinking, Denmark, Population, Breast Neoplasms, Smoking Prevention, Models, Biological, Young Adult, Breast cancer, SDG 3 - Good Health and Well-being, Risk Factors, Environmental health, Epidemiology, Medicine, Humans, Computer Simulation, Risk factor, Lung cancer, education, Aged, education.field_of_study, business.industry, Incidence (epidemiology), Incidence, Smoking, Cancer, Middle Aged, medicine.disease, Surgery, Oncology, Female, Breast disease, business, Forecasting
Abstract

Purpose: Among the known risk factors, smoking is clearly related to the incidence of lung cancer and alcohol consumption to breast cancer. In this manuscript we modeled the potential benefits of reductions in smoking or alcohol prevalence for the burden of these cancers. Method: We used Prevent v.3.01 to assess the changes in incidence as a result of risk factor changes. Incidence of lung and breast cancer until 2050 was predicted under two scenarios: ideal (total elimination of smoking and reduction of alcohol intake to maximum 1 units/d for women) and optimistic (decreasing prevalence of risk factors because of a 10% increase in cigarette and alcohol beverage price, repeated every 5 years). Danish data from the household surveys, cancer registration and Eurostat were used. Results: Up to 49% less new lung cancer cases can be expected in 2050 if smoking were to be completely eliminated. Five-yearly 10% price increases may prevent 521. new lung cancer cases in 2050 (21% less cases). An intervention that immediately reduces population alcohol consumption to the recommended level (below 12 g/d) may lower breast cancer by 7%, preventing 445 out of the 6060 expected new cases in 2050. Five-yearly 10% price increases in alcoholic beverages achieved a reduction of half as expected by the ideal scenario, i.e. 4% (262) preventable cases in 2050. Conclusions: The future burden of lung and breast cancer could be markedly reduced by intervening in their risk factors. Prevent illustrates the benefit of interventions and may serve as guidance in political decision-making. (C) 2010 Elsevier Ltd. All rights reserved.

Published
2010

27. The cancer survival gap between elderly and middle-aged patients in Europe is widening

Author

Stefano Guzzinati, Florence Molinié, Rafael Marcos-Gragera, Eva Ardanaz, Tiziana Cassetti, Angel Izquierdo Font, Milena Sant, Stanislaw Gozdz, Rafael Peris-Bonet, Marina Vercelli, Pascale Grosclaude, Emmanuel Desandes, Michel Coleman, Laura Ciccolallo, Lucia Mangone, Freddie Bray, Hermann Brenner, Giovanna Tagliabue, Mariano Santaquilani, Enrico Grande, Maria Zwierko, Emanuele Crocetti, Roberta De Angelis, Stefano Ferretti, Andrea Tavilla, Gemma Gatta, Silvia Francisci, Paolo Contiero, Rosario Tumino, Laufey Tryggvadottir, Franco Berrino, Hans Storm, Paolo Baili, David Brewster, Vesin, Aurélien, Liguria Cancer Registry, Descriptive Epidemiology Unit, National Cancer Research Institute, National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita [Rome], North West Cancer Intelligence Service, Christie Hospital NHS Foundation Trust, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine (LSHTM), Division of Clinical Epidemiology and Aging Research, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Registre des Cancers de l'Isère, registre des Cancers de l'Isère, Recherche en Epidémiologie et Prévention, and Tarn Cancer Registry

Subjects
Male, Oncology, Cancer Research, Prostate cancer, MESH: Aged, 80 and over, Breast cancer, Elderly, Neoplasms, 80 and over, Cancer registries, MESH: Neoplasms, Stomach cancer, Aged, 80 and over, MESH: Aged, Cervical cancer, MESH: Middle Aged, Relative survival, MESH: Sex Distribution, Middle Aged, Prognosis, Colon cancer, Europe, Uterus cancer, Prostatic cancer, MESH: Survival Analysis, Female, Breast disease, MESH: Life Expectancy, medicine.medical_specialty, Socio-culturale, MESH: Prognosis, Age Distribution, Life Expectancy, Ovarian cancer, Internal medicine, medicine, Humans, Sex Distribution, MESH: Age Distribution, Aged, Survival Analysis, Survival analysis, Gynecology, MESH: Humans, business.industry, Cancer, medicine.disease, MESH: Male, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Europe, business, MESH: Female
Abstract

International audience; The present study is aimed to compare survival and prognostic changes over time between elderly (70-84 years) and middle-aged cancer patients (55-69 years). We considered seven cancer sites (stomach, colon, breast, cervix and corpus uteri, ovary and prostate) and all cancers combined (but excluding prostate and non-melanoma skin cancers). Five-year relative survival was estimated for cohorts of patients diagnosed in 1988-1999 in a pool of 51 European populations covered by cancer registries. Furthermore, we applied the period-analysis method to more recent incidence data from 32 cancer registries to provide 1- and 5-year relative survival estimates for the period of follow-up 2000-2002. A significant survival improvement was observed from 1988 to 1999 for all cancers combined and for every cancer site, except cervical cancer. However, survival increased at a slower rate in the elderly, so that the gap between younger and older patients widened, particularly for prostate cancer in men and for all considered cancers except cervical cancer in women. For breast and prostate cancers, the increasing gap was likely attributable to a larger use of, respectively, mammographic screening and PSA test in middle-aged with respect to the elderly. In the period analysis of the most recent data, relative survival was much higher in middle-aged patients than in the elderly. The differences were higher for breast and gynaecological cancers, and for prostate cancer. Most of this age gap was due to a very large difference in survival after the 1st year following the diagnosis. Differences were much smaller for conditional 5-year relative survival among patients who had already survived the first year. The increase of survival in elderly men is encouraging but the lesser improvement in women and, in particular, the widening gap for breast cancer suggest that many barriers still delay access to care and that enhanced prevention and clinical management remain major issues.

Published
2009

28. Multiple tumours in survival estimates

Author

Stefano Guzzinati, Florence Molinié, Rafael Marcos-Gragera, Eva Ardanaz, Tiziana Cassetti, Angel Izquierdo Font, Milena Sant, Stanislaw Gozdz, Rafael Peris-Bonet, Pascale Grosclaude, Emmanuel Desandes, Michel Coleman, Laura Ciccolallo, Lucia Mangone, Freddie Bray, Hermann Brenner, Giovanna Tagliabue, Mariano Santaquilani, Enrico Grande, Maria Zwierko, Jan Willem Coebergh, Emanuele Crocetti, Giulia Zigon, Roberta De Angelis, Stefano Ferretti, Andrea Tavilla, Gemma Gatta, Silvia Francisci, Paolo Contiero, Rosario Tumino, Laufey Tryggvadottir, Franco Berrino, Hans Storm, Paolo Baili, David Brewster, National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita [Rome], Evaluative Epidemiology Unit, Fondazione IRCCS, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Neurology, and Public Health

Subjects
Male, Oncology, Cancer Research, Survival, MESH : Age Distribution, MESH : Aged, MESH : Neoplasms, Multiple Primary, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, Neoplasms, Multiple Primary, MESH: Aged, 80 and over, 0302 clinical medicine, Multiple Primary, Prostate, Neoplasms, Epidemiology, 80 and over, Cancer registries, MESH: Neoplasms, Multiple Primary, MESH : Female, 030212 general & internal medicine, Young adult, 10. No inequality, MESH : Sex Distribution, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Relative survival, Medicine (all), MESH: Sex Distribution, Multiple tumours, Neoplasm, Adolescent, Adult, Age Distribution, Aged, Europe, Female, Humans, Middle Aged, Sex Distribution, Survival Analysis, Young Adult, Percentage point, MESH : Adult, 3. Good health, Multiple tumours - survival estimates, medicine.anatomical_structure, MESH: Young Adult, MESH: Survival Analysis, 030220 oncology & carcinogenesis, medicine.medical_specialty, MESH : Male, MESH : Europe, MESH : Young Adult, Socio-culturale, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, MESH : Adolescent, medicine, MESH : Middle Aged, MESH : Aged, 80 and over, MESH: Age Distribution, Survival analysis, MESH: Adolescent, MESH: Humans, business.industry, MESH : Humans, Cancer, MESH: Adult, medicine.disease, MESH: Male, Surgery, Cancer registry, MESH: Europe, MESH : Survival Analysis, business, MESH: Female
Abstract

In international comparisons of cancer registry based survival it is common practice to restrict the analysis to first primary tumours and exclude multiple cancers. The probability of correctly detecting subsequent cancers depends on the registry's running time, which results in different proportions of excluded patients and may lead to biased comparisons. We evaluated the impact on the age-standardised relative survival estimates of also including multiple primary tumours. Data from 2,919,023 malignant cancers from 69 European cancer registries participating in the EUROCARE-4 collaborative study were used. A total of 183,683 multiple primary tumours were found, with an overall proportion of 6.3% over all the considered cancers, ranging from 0.4% (Naples, Italy) to 12.9% (Iceland). The proportion of multiple tumours varied greatly by type of tumour, being higher for those with high incidence and long survival (breast, prostate and colon-rectum). Five-year relative survival was lower when including patients with multiple cancers. For all cancers combined the average difference was -0.4 percentage points in women and -0.7 percentage points in men, and was greater for older registries. Inclusion of multiple tumours led to lower survival in 44 out of 45 cancer sites analysed, with the greatest differences found for larynx (-1.9%), oropharynx (-1.5%), and penis (-1.3%). Including multiple primary tumours in survival estimates for international comparison is advisable because it reduces the bias due to different observation periods, age, registration quality and completeness of registration. The general effect of inclusion is to reduce survival estimates by a variable amount depending on the proportion of multiple primaries and cancer site. (C) 2008 Elsevier Ltd. All rights reserved.

Published
2009

29. The advantage of women in cancer survival: An analysis of EUROCARE-4 data

Author

Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., de Vries, E., Izarzugaza, I., Zambon, P., Gatta, G., De Angelis, R., Hackl, M., Van Eycken, E., Verstreken, Martine, Holub, J., Jurickova, L., Storm, H. H., Engholm, G., Hakulinen, T., Belot, A., Hedelin, G., Velten, M., Tron, I., Le Gall, E., Launoy, G., Guizard, A. V., Faivre, J., Bouvier, A. M., Carli, P. M., Maynadie, M., Danzon, A., Buemi, A., Tretarre, B., Lacour, B., Desandes, E., Colonna, M., Molinie, F., Bara, S., Schvartz, C., Ganry, O., Grosclaude, P., Brenner, H., Kaatsch, P., Ziegler, H., Tryggvadottir, L., Comber, H., Berrino, F., Allemani, C., Baili, P., Sant, M., Sowe, S., Zigon, G., Tagliabue, G., Contiero, P., Bellu`, F., Giacomin, A., Ferretti, S., Serraino, D., Dal Maso, L., De Dottori, M., D. e. Paoli, A., Zanier, L., Vercelli, M., Orengo, M. A., Casella, C., Quaglia, A., Pannelli, F., Federico, M., Rashid, I., Cirilli, C., Fusco, M., Traina, A., De Lisi, V., Bozzani, F., Magnani, C., Pastore, G., Tumino, R., La Rosa, M. G., Spata, E., Sigona, A., Mangone, L., Falcini, F., Foca, F., Giorgetti, S., Senatore, G., Iannelli, A., Budroni, M., Patriarca, S., Zanetti, R., Rosso, S., Piffer, S., Franchini, S., Paci, E., Crocetti, E., La Rosa, F., Stracci, F., Cassetti, T., Guzzinati, S., Caldora, M., Capocaccia, R., Carrani, E., Francisci, S., Grande, E., Inghelmann, R., Lenz, H., Martina, L., Roazzi, P., Santaquilani, M., Simonetti, A., Tavilla, A., Verdecchia, A., Dalmas, M., Langmark, F., Bray, F., Johannesen, T. B., Rachtan, J., Gozdz, S., Siudowska, U., Mezyk, R., Bielska-Lasota, M., Zwierko, M., Pinheiro, P. S., Primic-Zakelj, M., Mateos, A., Torrella-Ramos, A., Zurriaga, Oscar, Marcos-Gragera, R., Vilardell, M. L., Izquierdo, A., Martinez-Garcia, C., Sanchez, M. J., Navarro, C., Chirlaque, M. D., Peris-Bonet, R., Ardanaz, E., Moreno, C., Galceran, J., Klint, A., Talback, M., Jundt, G., Usel, M., Frick, H., Ess, S. M., Bordoni, A., Luthi, J. C., Konzelmann, I., Probst, N., Lutz, J. M., Pury, P., Visser, O., Otter, R., Schaapveld, M., Coebergh, J. W. W., Janssen-Heijnen, M. L., Louis van der Heijden, Null, Greenberg, D. C., Coleman, M. P., Woods, Laura, Moran, T., Forman, D., Cooper, N., Roche, M., Verne, J., Mã¸ller, H., Meechan, D., Poole, J., Lawrence, G., Stiller, C., Gavin, A., Black, R. J., Brewster, D. H., Steward, J. A., Basque Country Cancer Registry, Vitoria-Gasteiz, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), and Public Health

Subjects
Oncology, Male, Pathology, Cancer Research, cancer survival - women, MESH : Age Distribution, MESH : Aged, MESH: Risk Assessment, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 0302 clinical medicine, MESH: Aged, 80 and over, Residence Characteristics, Neoplasms, 80 and over, Gender differences, Sex hormones, MESH: Neoplasms, MESH : Female, MESH: Residence Characteristics, Young adult, Age of Onset, MESH : Risk Assessment, MESH : Sex Distribution, MESH: Diagnosis-Related Groups, MESH: Aged, Aged, 80 and over, 0303 health sciences, education.field_of_study, MESH: Middle Aged, Relative survival, Thyroid, MESH: Sex Distribution, Middle Aged, MESH : Adult, 3. Good health, MESH : Age of Onset, Europe, MESH : Diagnosis-Related Groups, medicine.anatomical_structure, MESH: Young Adult, 030220 oncology & carcinogenesis, MESH: Survival Analysis, MESH : Residence Characteristics, Female, EUROCARE, Adult, medicine.medical_specialty, Adolescent, MESH: Age of Onset, MESH : Male, MESH : Sex Factors, Population, MESH : Europe, MESH : Young Adult, Rectum, Socio-culturale, [SDV.CAN]Life Sciences [q-bio]/Cancer, Risk Assessment, 03 medical and health sciences, Young Adult, Age Distribution, Sex Factors, MESH: Sex Factors, SDG 3 - Good Health and Well-being, Internal medicine, MESH : Adolescent, medicine, Humans, MESH : Middle Aged, Sex Distribution, education, MESH : Aged, 80 and over, MESH: Age Distribution, Survival analysis, Diagnosis-Related Groups, 030304 developmental biology, Aged, MESH: Adolescent, MESH: Humans, business.industry, MESH : Humans, Cancer, Cancer survival, Survival Analysis, MESH: Adult, medicine.disease, MESH : Neoplasms, MESH: Male, MESH: Europe, Age of onset, MESH : Survival Analysis, business, MESH: Female
Abstract

We analysed 1.6 million population-based EUROCARE-4 cancer cases (26 cancer sites, excluding sex-specific sites, and breast) from 23 countries to investigate the role of sex in cancer survival according to age at diagnosis, site, and European region. For 15 sites (salivary glands, head and neck, oesophagus, stomach, colon and rectum, pancreas, lung, pleura, bone, melanoma of skin, kidney, brain, thyroid, Hodgkin disease and non-Hodgkin's lymphoma) age- and region-adjusted relative survival was significantly higher in women than men. By multivariable analysis, women had significantly lower relative excess risk (RER) of death for the sites listed above plus multiple myeloma. Women significantly had higher RER of death for biliary tract, bladder and leukaemia. For all cancers combined women had a significant 5% lower RER of death. Age at diagnosis was the main determinant of the women's advantage, which, however, decreased with increasing age, becoming negligible in the elderly, suggesting that sex hormone patterns may have a role in women's superior ability to cope with cancer. (C) 2008 Elsevier Ltd. All rights reserved.

Published
2009

30. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994–2003

Author

Gitte Hvilsom, Fatima Birch-Johansen, Hans H. Storm, and Trille Kristina Kjaer

Subjects
Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Denmark, Sunburn, Cohort Studies, Epidemiology, medicine, Humans, Melanoma, Socioeconomic status, Aged, Demography, business.industry, Incidence, Incidence (epidemiology), Cancer, Middle Aged, medicine.disease, Surgery, Socioeconomic Factors, Oncology, Cohort, Female, business, Cohort study
Abstract

The incidence of cutaneous malignant melanoma has increased more than that of any other cancer in most white populations during the past few decades. We investigated the effects of socioeconomic, demographic and health-related indicators on the incidence of and survival from malignant melanoma in 1994-2003 in Denmark using information from nationwide registries. The analyses were based on data on 6914 patients with malignant melanoma in a cohort of 3.22 million persons born between 1925 and 1973 and aged >or=30 years. The age- and period-standardised incidence rate was 25 and 29 per 100,000 person-years for men and women, respectively. We found an increased risk for malignant melanoma in the highest socioeconomic groups. In general, survival after a malignant melanoma was better in high socioeconomic groups and better in women than men. Our results support earlier reports that malignant melanoma is associated with higher socioeconomic position.

Published
2008

31. Geographical variability in survival of European children with central nervous system tumours

Author

Gatta, G., primary, Peris-Bonet, R., additional, Visser, O., additional, Stiller, C., additional, Marcos-Gragera, R., additional, Sánchez, M.-J., additional, Lacour, B., additional, Kaatsch, P., additional, Berrino, F., additional, Rutkowski, S., additional, Botta, L., additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Faivre, J., additional, Bossard, N., additional, Uhry, Z., additional, Colonna, M., additional, Clavel, J., additional, Desandes, E., additional, Brenner, H., additional, Katalinic, A., additional, Garami, M., additional, Jakab, Z., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Barchielli, A., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Bonfarnuzzo, S., additional, Capocaccia, R., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Zucchetto, A., additional, De Angelis, R., additional, Caldora, M., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Filiberti, R.A., additional, Marani, E., additional, Ricci, P., additional, Pascucci, C., additional, Autelitano, M., additional, Spagnoli, G., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Merletti, F., additional, Maule, M., additional, Tumino, R., additional, Mangone, L., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Rugge, M., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Góźdź, S., additional, Mężyk, R., additional, Błaszczyk, J., additional, Bębenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Vicente Raneda, M., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Chang, D.Y.L., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Pardo Romaguera, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Aarts, M., additional, Otter, R., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Gavin, A., additional, Donnelly, C., additional, and Brewster, D.H., additional

Published
2017
Full Text
View/download PDF

32. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

Author

Dal Maso, L., primary, Tavilla, A., additional, Pacini, F., additional, Serraino, D., additional, van Dijk, B.A.C., additional, Chirlaque, M.D., additional, Capocaccia, R., additional, Larrañaga, N., additional, Colonna, M., additional, Agius, D., additional, Ardanaz, E., additional, Rubió-Casadevall, J., additional, Kowalska, A., additional, Virdone, S., additional, Mallone, S., additional, Amash, H., additional, De Angelis, R., additional, Hackl, M., additional, Zielonke, N., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Dušek, L., additional, Zvolský, M., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Guizard, A.V., additional, Faivre, J., additional, Woronoff, A.S., additional, Tretarre, B., additional, Bossard, N., additional, Uhry, Z., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mazzei, A., additional, Ferretti, S., additional, Barchielli, A., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Zucchetto, A., additional, Caldora, M., additional, Carrani, E., additional, Francisci, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Pannozzo, F., additional, Busco, S., additional, Filiberti, R.A., additional, Vercelli, M., additional, Ricci, P., additional, Autelitano, M., additional, Spagnoli, G., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Mangone, L., additional, Vicentini, M., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Rocca, A., additional, Tagliabue, G., additional, Contiero, P., additional, Rugge, M., additional, Tognazzo, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Johannesen, T.B., additional, Rachtan, J., additional, Góźdź, S., additional, Mężyk, R., additional, Błaszczyk, J., additional, Bębenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Molina, E., additional, Navarro, C., additional, Moreno-Iribas, C., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Ho, V., additional, Otter, R., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Rashbass, J., additional, Broggio, J., additional, Verne, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, and White, C., additional

Published
2017
Full Text
View/download PDF

34. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?—A population-based study

Author

Torgil Möller, S Hein, Mats Andersson, Hans H. Storm, Henning T. Mouridsen, Jeanette Ceberg, Gerda Engholm, UB Tange, Christensen Lh, and Roland Perfekt

Subjects
Cancer Research, medicine.medical_specialty, Denmark, Population, Breast Neoplasms, Danish, Breast cancer, medicine, Humans, Age of Onset, education, Sweden, education.field_of_study, Relative survival, business.industry, Mortality rate, Hazard ratio, Prognosis, medicine.disease, language.human_language, Cancer registry, Surgery, Oncology, language, Female, Age of onset, Epidemiologic Methods, business, Demography
Abstract

Analyses of data from cancer registries have shown a 10% unit difference in 5-year relative survival between Danish and Swedish patients with breast cancer. This study investigates the effect of age and patho-anatomic variables on this survival difference. Hospital records were collected for women over 40 years of age diagnosed in 1989 or 1994 in east Denmark and south Sweden; patho-anatomical variables and survival were compared between 2289 Danish and 1715 Swedish women. Tumours were smaller, node-negative axillae more frequent and well-differentiated tumours almost 10% more frequent in Sweden. A superior 5-year relative survival in Sweden was found in the 50- to 79-year age group. The adjusted hazard rate ratio between countries was 1.7 in 1989 and 1.3 in 1994. Conditional survival after surviving the first 5 years was similar for the two countries. Adjusting for patho-anatomical variables reduced but did not eliminate the higher risk of death among the Danish patients. Higher population death rates could explain some but not all of the residual elevated risk for Danish women.

Published
2004

35. Survival of children with thyroid cancer in Europe 1978–1989

Author

Eva Ardanaz, Magdalena Bielska-Lasota, Milena Sant, Michel Coleman, Lucia Mangone, Jan Willem Coebergh, Gemma Gatta, Fabio Falcini, Rosario Tumino, Jadwiga Rachtan, and Hans Storm

Subjects
Male, Cancer Research, medicine.medical_specialty, Adolescent, Age Distribution, Residence Characteristics, Epidemiology, Humans, Medicine, Registries, Thyroid Neoplasms, Sex Distribution, Child, Thyroid cancer, Survival analysis, Childhood Cancer Registry, business.industry, Incidence, Incidence (epidemiology), Thyroid, Infant, Newborn, Infant, Cancer, medicine.disease, Survival Analysis, Europe, Survival Rate, medicine.anatomical_structure, Oncology, El Niño, Child, Preschool, Regression Analysis, Female, business, Demography
Abstract

Thyroid cancers are rare in childhood with between 0.4 and 1.5 cases per million, 2–3 times as frequent in girls as in boys. However, following the Chernobyl accident, a remarkable incidence increase was observed in children exposed to radioactive iodine fall-out. Survival after thyroid cancer in childhood is thus of interest. In the EUROCARE II study, excluding most of Eastern Europe, a total of 165 childhood thyroid cancers were reported during the period 1978–1989, of which 134 were aged 10–14 years. The childhood cancer registry in England and Wales contributed 39% of the cases, and another 24% came from the Nordic countries, the rest from other parts of west, south, east and central Europe. The 5-year survival was for both genders combined 97% (95% confidence interval (CI): 93–99), 98% (95% CI: 91–100) for boys and 97% (95% CI: 91–99) for girls, with no significant difference between the genders. Survival was high during the entire study period, and variations influenced by the small numbers. As for adults, long-term follow-up beyond 10–20 years is needed to clearly demonstrate excess mortality as a consequence of the cancer.

Published
2001

37. Survival of adult patients with cancer of soft tissues or bone in Europe

Author

Eva Ardanaz, Magdalena Bielska-Lasota, Milena Sant, Michel Coleman, Lucia Mangone, Jan Willem Coebergh, Gemma Gatta, Fabio Falcini, Rosario Tumino, Jadwiga Rachtan, and Hans Storm

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Relative survival, business.industry, Bone cancer, Soft tissue sarcoma, Cancer, medicine.disease, Surgery, Eastern european, Internal medicine, Epidemiology, medicine, Sarcoma, business, Survival analysis
Abstract

Using data from the EUROCARE II database, relative survival rates for Europe were studied for adult patients with soft tissue sarcomas (STS) and bone cancers separately. Altogether 2,151 bone cancers and 5,845 STS were included. Survival analysis was carried out for each gender and the ratio between observed and expected survival calculated. One-year relative survival for bone cancer was 65% in men and 71% in women, and 5-year relative survival 45% in men and 51% in women. For STS 1-year relative survival was 78% for men and 79% for women and 5-year relative survival was 59% for both sexes. The variation in relative survival for bone cancer between countries was substantial, with the lowest rates seen in the Eastern countries. Denmark had the lowest rates of the Nordic countries, similar to those of Scotland. The variation in survival rates for STS was less pronounced, but still rates tended to be lower in Eastern European countries. The present analysis was carried out in the subset of European STS excluding visceral STS. To assess fully the international variation in survival a review of STS based on reported sarcoma morphology must be carried out.

Published
1998

40. Problems related to the coding of multiple primary cancers

Author

Emanuele Crocetti, Hans H. Storm, S. Lecker, and Eva Buiatti

Subjects
Cancer Research, medicine.medical_specialty, Kappa value, business.industry, Denmark, Incidence, International Cooperation, Comparability, Cancer, medicine.disease, language.human_language, Cancer registry, Neoplasms, Multiple Primary, Danish, Italy, Oncology, Family medicine, language, medicine, Humans, Registries, business, Kappa, Coding (social sciences)
Abstract

There is growing interest in multiple primary cancers (MPs), but the lack of a universally agreed definition can both modify the results for one series and hamper comparisons among cancer registries. The aim of this study was to compare agreement on the coding of MPs between two cancer registries, the Danish Cancer Registry and the Tuscany Tumour Registry, that adhere to different rules for accepting MPs, and to study whether coding according to common international rules (IACR) would increase the comparability. Data on 200 patients recorded as having more than one cancer were extracted at random from the two registers. The agreement on MP status between coders, one from each registry, using local rules and definitions on MP, was good (kappa value, 0.70). Exclusion of 11 expected discordant cases increased the agreement (kappa = 0.86). The agreement reached with the use of the IACR rules was very high (kappa = 0.80). We conclude that registries should present data according to international rules, in particular for the study of MPs. Registries should at least clearly indicate deviations from the agreed international standards, in order to facilitate comparisons on incidences.

Published
1996

41. Incidence of second primary cancer following testicular cancer

Author

Hans H. Storm, Henrik Møller, Anders Mellemgaard, G.K. Jacobsen, and D. Pedersen

Subjects
Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Neoplasms, Radiation-Induced, Skin Neoplasms, Colorectal cancer, Denmark, Dysgerminoma, Prostate cancer, Breast cancer, Testicular Neoplasms, Risk Factors, Stomach Neoplasms, Internal medicine, Epidemiology of cancer, Humans, Medicine, Testicular cancer, Rectal Neoplasms, business.industry, Incidence, Cancer, Neoplasms, Second Primary, Middle Aged, medicine.disease, Pancreatic Neoplasms, Skin cancer, business, Kidney cancer
Abstract

The incidence of second primary cancers was investigated in 6187 Danish men diagnosed with testicular cancer in the period 1943-1987. During the course of 59,000 person years, 459 subsequent primary cancers occurred. The relative risks were significantly increased for leukaemia, gastric cancer, pancreatic cancer, bladder cancer, non-melanoma skin cancer and kidney cancer. Increased incidence was furthermore suggested for cancer of the rectum, prostate and lung. The increased incidence of leukaemia appeared in the first 10 years after testicular cancer diagnosis. The excess incidence for gastric cancer, pancreatic cancer, rectal cancer and lung cancer was strongest 10-19 years after testicular cancer, while the relative risk of non-melanoma skin cancer and prostate cancer increased throughout the period of follow-up. The increased incidence of cancer in this cohort is most likely an effect of radiotherapy used for testicular cancer. It is proposed that the different incidence patterns over time after testicular cancer diagnosis reflect differences in the growth rate of tumours originating in different tissues.

Published
1993

42. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

Author

De Angelis, Roberta, primary, Minicozzi, Pamela, additional, Sant, Milena, additional, Dal Maso, Luigino, additional, Brewster, David H., additional, Osca-Gelis, Gemma, additional, Visser, Otto, additional, Maynadié, Marc, additional, Marcos-Gragera, Rafael, additional, Troussard, Xavier, additional, Agius, Dominic, additional, Roazzi, Paolo, additional, Meneghini, Elisabetta, additional, Monnereau, Alain, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Crocetti, E., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Dal Maso, L., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Staiti, R., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Bebenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Ramírez, C., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Jimenez-Chillaron, R., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Chang, D.Y.L., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Lemmens, V., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

43. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study

Author

Trama, Annalisa, primary, Foschi, Roberto, additional, Larrañaga, Nerea, additional, Sant, Milena, additional, Fuentes-Raspall, Rafael, additional, Serraino, Diego, additional, Tavilla, Andrea, additional, Van Eycken, Liesbet, additional, Nicolai, Nicola, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Crocetti, E., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Dal Maso, L., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, F. Vitale, M., additional, Usala, M., additional, Traina, A., additional, Staiti, R., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Bebenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Ramírez, C., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Jimenez-Chillaron, R., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, J. Sanchez, M., additional, Chang, D.Y.L., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, M. Ess, S., additional, Frick, H., additional, Lorez, M., additional, Ess, S.M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Verhoeven, R., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

44. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study

Author

Holleczek, Bernd, primary, Rossi, Silvia, additional, Domenic, Agius, additional, Innos, Kaire, additional, Minicozzi, Pamela, additional, Francisci, Silvia, additional, Hackl, Monika, additional, Eisemann, Nora, additional, Brenner, Hermann, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mazzei, A., additional, Ferretti, S., additional, Crocetti, E., additional, Manneschi, G., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Zucchetto, A., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Natali, M., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Zarcone, M., additional, Vitale, F., additional, Cusimano, R., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Vicentini, M., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Rocca, A., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Tognazzo, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Micallef, R., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Kepska, K., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Antunes, L., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Mateos, A., additional, Errezola, M., additional, Larrañaga, N., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Marcos-Gragera, R., additional, Vilardell, L., additional, Sanchez, M.J., additional, Molina, E., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Lemmens, V., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Fitzpatrick, D., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

45. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

Author

Gatta, Gemma, primary, Botta, Laura, additional, Sánchez, María José, additional, Anderson, Lesley Ann, additional, Pierannunzio, Daniela, additional, Licitra, Lisa, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A. Mazzei, A., additional, Ferretti, S., additional, Crocetti, E., additional, Manneschi, G., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Zucchetto, A., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Natali, M., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Zarcone, M., additional, Vitale, F., additional, Cusimano, R., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Vicentini, M., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Rocca, A., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Tognazzo, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Micallef, R., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Kepska, K., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Antunes, L., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Mateos, A., additional, Errezola, M., additional, Larrañaga, N., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Marcos-Gragera, R., additional, Vilardell, L., additional, Sanchez, M.J., additional, Molina, E., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, van Dijk, B., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Fitzpatrick, D., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

46. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5

Author

Lepage, Côme, primary, Capocaccia, Riccardo, additional, Hackl, Monika, additional, Lemmens, Valerie, additional, Molina, Esther, additional, Pierannunzio, Daniela, additional, Sant, Milena, additional, Trama, Annalisa, additional, Faivre, Jean, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Crocetti, E., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Dal Maso, L., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Staiti, R., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Bebenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Ramírez, C., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Jimenez-Chillaron, R., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Chang, D.Y.L., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, van der Geest, L., additional, Otter, R., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, and White, C., additional

Published
2015
Full Text
View/download PDF

47. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study

Author

Baili, Paolo, primary, Di Salvo, Francesca, additional, Marcos-Gragera, Rafael, additional, Siesling, Sabine, additional, Mallone, Sandra, additional, Santaquilani, Mariano, additional, Micheli, Andrea, additional, Lillini, Roberto, additional, Francisci, Silvia, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mazzei, A., additional, Ferretti, S., additional, Crocetti, E., additional, Manneschi, G., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Zucchetto, A., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Natali, M., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Zarcone, M., additional, Vitale, F., additional, Cusimano, R., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Vicentini, M., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Rocca, A., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Tognazzo, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Micallef, R., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Kepska, K., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Antunes, L., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Mateos, A., additional, Errezola, M., additional, Larrañaga, N., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Marcos-Gragera, R., additional, Vilardell, L., additional, Sanchez, M.J., additional, Molina, E., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Lemmens, V., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Fitzpatrick, D., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

48. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5

Author

Marcos-Gragera, Rafael, primary, Mallone, Sandra, additional, Kiemeney, Lambertus A., additional, Vilardell, Loreto, additional, Malats, Núria, additional, Allory, Yves, additional, Sant, Milena, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, M. Bouvier, A., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mazzei, A., additional, Ferretti, S., additional, Crocetti, E., additional, Manneschi, G., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Zucchetto, A., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Zarcone, M., additional, Vitale, F., additional, Cusimano, R., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Vicentini, M., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Rocca, A., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Tognazzo, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Micallef, R., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Kepska, K., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Antunes, L., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Mateos, A., additional, Errezola, M., additional, Larrañaga, N., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Marcos-Navarro, A.I., additional, Marcos-Gragera, R., additional, Vilardell, L., additional, Sanchez, M.J., additional, Molina, E., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Aben, K., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Fitzpatrick, D., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

49. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5

Author

Anderson, L.A., primary, Tavilla, A., additional, Brenner, H., additional, Luttmann, S., additional, Navarro, C., additional, Gavin, A.T., additional, Holleczek, B., additional, Johnston, B.T., additional, Cook, M.B., additional, Bannon, F., additional, Sant, M., additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dusek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Eberle, A., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Crocetti, E., additional, Caldarella, A., additional, Gatta, G., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Dal Maso, L., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Staiti, R., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Bebenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Ramírez, C., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Jimenez-Chillaron, R., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Chang, D.Y.L., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Verhoeven, R., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

50. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study

Author

Sant, Milena, primary, Chirlaque Lopez, Maria Dolores, additional, Agresti, Roberto, additional, Sánchez Pérez, Maria José, additional, Holleczek, Bernd, additional, Bielska-Lasota, Magdalena, additional, Dimitrova, Nadya, additional, Innos, Kaire, additional, Katalinic, Alexander, additional, Langseth, Hilde, additional, Larrañaga, Nerea, additional, Rossi, Silvia, additional, Siesling, Sabine, additional, Minicozzi, Pamela, additional, Hackl, M., additional, Zielonke, N., additional, Oberaigner, W., additional, Van Eycken, E., additional, Henau, K., additional, Valerianova, Z., additional, Dimitrova, N., additional, Sekerija, M., additional, Zvolský, M., additional, Dušek, L., additional, Storm, H., additional, Engholm, G., additional, Mägi, M., additional, Aareleid, T., additional, Malila, N., additional, Seppä, K., additional, Velten, M., additional, Troussard, X., additional, Bouvier, V., additional, Launoy, G., additional, Guizard, A.V., additional, Faivre, J., additional, Bouvier, A.M., additional, Arveux, P., additional, Maynadié, M., additional, Woronoff, A.S., additional, Robaszkiewicz, M., additional, Baldi, I., additional, Monnereau, A., additional, Tretarre, B., additional, Bossard, N., additional, Belot, A., additional, Colonna, M., additional, Molinié, F., additional, Bara, S., additional, Schvartz, C., additional, Lapôtre-Ledoux, B., additional, Grosclaude, P., additional, Meyer, M., additional, Stabenow, R., additional, Luttmann, S., additional, Eberle, A., additional, Brenner, H., additional, Nennecke, A., additional, Engel, J., additional, Schubert-Fritschle, G., additional, Kieschke, J., additional, Heidrich, J., additional, Holleczek, B., additional, Katalinic, A., additional, Jónasson, J.G., additional, Tryggvadóttir, L., additional, Comber, H., additional, Mazzoleni, G., additional, Bulatko, A., additional, Buzzoni, C., additional, Giacomin, A., additional, Sutera Sardo, A., additional, Mancuso, P., additional, Ferretti, S., additional, Crocetti, E., additional, Caldarella, A., additional, Gatta, G., additional, Sant, M., additional, Amash, H., additional, Amati, C., additional, Baili, P., additional, Berrino, F., additional, Bonfarnuzzo, S., additional, Botta, L., additional, Di Salvo, F., additional, Foschi, R., additional, Margutti, C., additional, Meneghini, E., additional, Minicozzi, P., additional, Trama, A., additional, Serraino, D., additional, Dal Maso, L., additional, De Angelis, R., additional, Caldora, M., additional, Capocaccia, R., additional, Carrani, E., additional, Francisci, S., additional, Mallone, S., additional, Pierannunzio, D., additional, Roazzi, P., additional, Rossi, S., additional, Santaquilani, M., additional, Tavilla, A., additional, Pannozzo, F., additional, Busco, S., additional, Bonelli, L., additional, Vercelli, M., additional, Gennaro, V., additional, Ricci, P., additional, Autelitano, M., additional, Randi, G., additional, Ponz De Leon, M., additional, Marchesi, C., additional, Cirilli, C., additional, Fusco, M., additional, Vitale, M.F., additional, Usala, M., additional, Traina, A., additional, Staiti, R., additional, Vitale, F., additional, Ravazzolo, B., additional, Michiara, M., additional, Tumino, R., additional, Giorgi Rossi, P., additional, Di Felice, E., additional, Falcini, F., additional, Iannelli, A., additional, Sechi, O., additional, Cesaraccio, R., additional, Piffer, S., additional, Madeddu, A., additional, Tisano, F., additional, Maspero, S., additional, Fanetti, A.C., additional, Zanetti, R., additional, Rosso, S., additional, Candela, P., additional, Scuderi, T., additional, Stracci, F., additional, Bianconi, F., additional, Tagliabue, G., additional, Contiero, P., additional, Dei Tos, A.P., additional, Guzzinati, S., additional, Pildava, S., additional, Smailyte, G., additional, Calleja, N., additional, Agius, D., additional, Johannesen, T.B., additional, Rachtan, J., additional, Gózdz, S., additional, Mezyk, R., additional, Blaszczyk, J., additional, Bebenek, M., additional, Bielska-Lasota, M., additional, Forjaz de Lacerda, G., additional, Bento, M.J., additional, Castro, C., additional, Miranda, A., additional, Mayer-da-Silva, A., additional, Nicula, F., additional, Coza, D., additional, Safaei Diba, C., additional, Primic-Zakelj, M., additional, Almar, E., additional, Ramírez, C., additional, Errezola, M., additional, Bidaurrazaga, J., additional, Torrella-Ramos, A., additional, Díaz García, J.M., additional, Jimenez-Chillaron, R., additional, Marcos-Gragera, R., additional, Izquierdo Font, A., additional, Sanchez, M.J., additional, Chang, D.Y.L., additional, Navarro, C., additional, Chirlaque, M.D., additional, Moreno-Iribas, C., additional, Ardanaz, E., additional, Galceran, J., additional, Carulla, M., additional, Lambe, M., additional, Khan, S., additional, Mousavi, M., additional, Bouchardy, C., additional, Usel, M., additional, Ess, S.M., additional, Frick, H., additional, Lorez, M., additional, Herrmann, C., additional, Bordoni, A., additional, Spitale, A., additional, Konzelmann, I., additional, Visser, O., additional, Lemmens, V., additional, Coleman, M., additional, Allemani, C., additional, Rachet, B., additional, Verne, J., additional, Easey, N., additional, Lawrence, G., additional, Moran, T., additional, Rashbass, J., additional, Roche, M., additional, Wilkinson, J., additional, Gavin, A., additional, Donnelly, C., additional, Brewster, D.H., additional, Huws, D.W., additional, White, C., additional, and Otter, R., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results